Tocilizumab reduces mortality risk in severe COVID-19 patients

Objectives:
People who are exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could develop a potentially fatal disease with lung involvement and severe cytokine storm syndrome (CSS) - coronavirus disease 2019 (COVID-19). Tocilizumab (TCZ) was administered to these subjects, despite the lack of randomized clinical trial data. Hence, summarizing data on the mortality rate and related risks factors may help physicians to correctly administer tocilizumab. Therefore, this review article has been conducted.

Face mask may reduce primary respiratory infection risk by 6-15%

Face mask may reduce primary respiratory infection risk by 6-15%

Objectives:

Evidence for face-mask wearing in the community to protect against respiratory disease is unclear. Therefore, this review article has been conducted.

Do wearing face masks reduce primary respiratory infection risk?

Study design:
This review article included 33 studies (12 randomised control trials (RCTs)).

Children account for a small proportion of COVID-19 in household transmission cluster

Objectives:
The role of children in the spread of SARS-CoV-2 (COVID-19) remains highly controversial. Therefore, this review article has been conducted.

What is the role of children in SARS-CoV-2 in household transmission cluster?

Study design:
This review article included household SARS-CoV-2 transmission clusters (n = 213 from 12 countries).

Results and conclusions:   
The investigators found only 8 (3.8%) transmission clusters were identified as having a paediatric index case.

Calcium + vitamin D supplementation reduce hip fracture in postmenopausal women

Objectives:
Does calcium combined with vitamin D supplementation reduce risk of osteoporosis in postmenopausal women?

Study design:
This review article included 10 RCTs.

Results and conclusions:
The investigators found calcium combined with vitamin D supplementation significantly increased total bone mineral density [SMD = 0.537, 95% CI = 0.227 to 0.847] in postmenopausal women.

COVID-19 patients from North American, European and Middle East countries suffer more severe liver, kidney and heart damage

Objectives:
Are there differences in clinical manifestations between COVID-19 patients from the East (East and South-East Asian countries including China, South Korea and Thailand) and the West (North American, European and Middle East countries, including the United States, Italy, France and Iran)?

Study design:
This review article included 57 studies, describing 19,353 patients. Of these, 45 studies with 8,416 patients were from the East, while 12 studies with 10,937 patients were from the West.